Brain Natriuretic Peptide and Other Risk Markers for Outcome Assessment in Patients With Non-ST-Elevation Coronary Syndromes and Preserved Systolic Function

American Journal of Cardiology

Volumn 98, Issue 10, 2006, Pages 1322-1328

  Palazzuoli, Alberto ^a   Deckers, Jaap ^b   Calabrò, Anna ^a   Campagna, Maria Stella ^a   Nuti, Ranuccio ^a   Pastorelli, Marcello ^a   Pasqui, Anna Laura ^a   Bruni, Fulvio ^a   Auteri, Alberto ^a   Puccetti, Luca ^a  

^a UNIVERSITY OF SIENA   (Italy)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; CALCIUM ANTAGONIST; CLOPIDOGREL; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; NITRATE; TIROFIBAN; TROPONIN T;

ADULT; AGE DISTRIBUTION; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR RISK; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; DISEASE SEVERITY; ECHOCARDIOGRAPHY; FEMALE; HEART FAILURE; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE REVASCULARIZATION; HEART VENTRICLE CONTRACTION; HOSPITAL ADMISSION; HUMAN; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; Q WAVE; RISK ASSESSMENT; SEX RATIO; ST SEGMENT; ST SEGMENT ELEVATION; STABLE ANGINA PECTORIS; STATISTICAL SIGNIFICANCE; UNSTABLE ANGINA PECTORIS;

AGED; ANALYSIS OF VARIANCE; ANGINA PECTORIS; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CORONARY ANGIOGRAPHY; ECHOCARDIOGRAPHY; FEMALE; HUMANS; LINEAR MODELS; MALE; MYOCARDIAL INFARCTION; NATRIURETIC PEPTIDE, BRAIN; PREDICTIVE VALUE OF TESTS; RISK FACTORS; SYSTOLE; TROPONIN T;

EID: 33750513635     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2006.06.023     Document Type: Article

References (30)

1. Antman E.M., Cohen M., Bernink P.J., McCabe C.H., Horacek T., Papuchis G., Mautner B., Corbalan R., Radley D., and Braunwald E. The TIMI risk score for unstable angina/non ST elevation MI: a method for prognostication and therapeutic decision making. JAMA 284 (2000) 835-842
2. Braunwald E. Unstable angina: an etiologic approach to management. Circulation 98 (1998) 2119-2222
3. Lindahl B., Toss H., Siegbahn A., Venge P., and Wallentin L. Markers of myocardial damage and inflammation in relation to long term mortality in unstable coronary artery disease: FRISC Study Group. N Engl J Med 343 (2000) 1139-1147
4. Morrow D.A., and Braunwald E. Future of biomarkers in acute coronary syndromes moving toward multimarker strategy. Circulation 108 (2003) 250-252
5. Arakawa N., Nakamura M., Aoki H., and Hiramori K. Plasma brain natriuretic peptide concentrations predict survival after acute myocardial infarction. J Am Coll Cardiol 27 (1996) 1656-1661
6. Sabatine M.S., Morrow D.A., De Lemos J.A., Gibson C.M., Murphy S.A., Rifai N., McCabe C., Antman E.M., Cannon C.P., and Braunwald E. Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes. Circulation 105 (2002) 1760-1763
7. FRISC-II Study Group. Invasive compared with non-invasive treatment in unstable coronary-artery disease: FRISC II prospective randomised multicenter study. Lancet 354 (1999) 708-715
8. Antman E.M., McCabe C.H., Gurfinkel E.P., Turpie A.G., Bernink P.J., Salein D., Bayes De Luna A., Fox K., Lablanche J.M., Radley D., et al. Enoxaparin prevents death and cardiac ischemic events in unstable angina/non-Q-wave myocardial infarction. Results of the Thrombolysis In Myocardial Infarction (TIMI) 11B trial. Circulation 100 (1999) 1593-1601
9. Rutherford J.D., and Braunwald E. Coronary heart disease. In: Braunwald E. (Ed). Heart Diseases. 5th Ed. Vol 2 (1997) 1799-1869
10. de Lemos J.A., Morrow D.A., Bentley J.H., Omland T., Sabatine M.S., McCabe C.H., Hall C., Cannon C.P., and Braunwald E. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. N Engl J Med 345 (2001) 1014-1021
11. Zairis M.N., Lyras A.G., Bibis G.P., Patsourakos N.G., Makrygiannis S.S., Kardoulas A.D., Glyptis M.P., Prekates A.A., Cokkinos D.V., and Foussas S.G. Association of inflammatory biomarkers and cardiac troponin I with multifocal activation of coronary artery tree in the setting of non-ST-elevation acute myocardial infarction. Atherosclerosis 182 (2005) 161-167
12. James S.K., Armstrong P., Barnathan E., Califf R., Lindahl B., Siegbahn A., Simoons M.L., Topol E.J., Venge P., and Wallentin L. Troponin and C-reactive protein have different relations to subsequent mortality and myocardial infarction after acute coronary syndrome. J Am Coll Cardiol 41 (2003) 916-924
13. Lindahl B., Diderholm E., Lagerqvist B., Venge P., and Wallentin L. Mechanisms behind the prognostic value of troponin T in unstable coronary artery disease: a FRISC II substudy. J Am Coll Cardiol 38 (2001) 979-986
14. Rebuzzi A.G., Quaranta G., Liuzzo G., Caligiuri G., Lanza G.A., Gallimore J.R., Grillo R.L., Cianflone D., Biasucci L.M., and Maseri A. Incremental prognostic value of serum level of troponin T and C reactive protein on admission in patients with unstable angina pectoris. Am J Cardiol 82 (1998) 715-719
15. Chew D.P., Bhatt D.L., Robbins M.A., Penn M.S., Schneider J.P., Lauer M.S., Topol E.J., and Ellis S.G. Incremental prognostic value of elevated baseline C-reactive protein among established markers of risk in percutaneous coronary intervention. Circulation 104 (2001) 992-997
16. Toss H., Lindahl B., Siegbahn A., Wallentin L., and FRISC Study Group. Prognostic influence of increased fibrinogen and C-reactive protein levels in unstable coronary artery disease. Circulation 96 (1997) 4204-4210
17. Liuzzo G., Biasucci L.M., Gallimore J.R., Grillo R.L., Rebuzzi A.G., Pepys M.B., and Maseri A. The prognostic value of C reactive protein and serum amyloid A protein in severe unstable angina. N Engl J Med 331 (1994) 417-424
18. De Winter R., Bholasingh R., Lijmer J.G., Koster R.W., Gorgels J.P., Schouten Y., Hoek F.J., and Sanders G.T. Independent prognostic value of C-reactive protein and troponin I in patients with unstable angina or non-Q-wave myocardial infarction. Cardiovasc Res 42 (1999) 240-245
19. Caligiuri G., Liuzzo G., Biasucci L.M., and Maseri A. Immune system activation follows inflammation in unstable angina: pathogenetic implications. J Am Coll Cardiol 32 (1998) 1295-1304
20. Cermak J., Key N.S., Bach R.R., Balla J., Jacob H.S., and Vercellotti G.M. C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor. Blood 82 (1993) 513-520
21. Morrow D.A., de Lemos J., Sabatine M., Murphy S.A., Demoupoulos L.A., DiBattiste P.M., McCabe C.H., Gibson M., Cannon C.P., and Braunwald E. Evaluation of B type natriuretic peptide for risk assessment in unstable angina/non-ST myocardial infarction (TACTIS-TIMI 18). J Am Coll Cardiol 41 (2003) 1264-1272
22. Omland T., Aakvaag A., Bonarjee V.V., Caidahl K., Lie R.T., Nilsen D.W., Sundsfjord J.A., and Dickstein K. Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction: comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide. Circulation 93 (1996) 1963-1969
23. James S.K., Lindahl B., Siegbahn A., and Stridsberg M. N-terminal pro-brain natriuretic peptide and other risk markers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary artery disease: a Global Utilization of Strategies To Open occluded arteries (GUSTO)-IV substudy. Circulation 108 (2003) 275-281
24. Marumoto K., Hamada M., and Hiwada K. Increased secretion of atrial and brain natriuretic peptides during acute myocardial ischaemia induced by dynamic exercise in patients with angina pectoris. Clin Sci (Colch) 88 (1995) 551-556
25. Heeschen C., Hamm C.W., Mitrovic V., Lantelme N.H., and White H.D. N-terminal pro-B-type natriuretic peptide levels for dynamic risk stratification of patients with acute coronary syndromes. Circulation 110 (2004) 3206-3212
26. Kikuta K., Yasue H., Yoshimura M., Morita, Sumida H., Kato H., Kugiyama K., Ogawa H., Okumura K., Ogawa Y., and Nakao K. Kumamoto and Kyoto. Increased plasma levels of B-type natriuretic peptide in patients with unstable angina. Am Heart J 132 (1996) 101-107
27. Sadanandan S., Cannon C.P., Chekuri K., Murphy S.A., Dibattiste P.M., Morrow D.A., de Lemos J.A., Braunwald E., and Gibson C.M. Association of elevated B-type natriuretic peptide levels with angiographic findings among patients with unstable angina and non-ST-segment elevation myocardial infarction. J Am Coll Cardiol 44 (2004) 564-568
28. Palazzuoli A., Gennari L., Calabria P., Quatrini I., Vecchiato L., De Paola V., Campagna M.S., Palazzuoli V., and Nuti R. Relation of plasma brain natriuretic peptide levels in non-ST elevation coronary disease and preserved systolic function to number of narrowed coronary arteries. Am J Cardiol 96 (2005) 1705-1710
29. Talwar S., Squire I.B., Downie P.F., Davies J.E., and Ng L.L. Plasma N-terminal pro-brain natriuretic peptide and cardiotrophin 1 are raised in unstable angina. Heart 84 (2000) 421-424
30. Bazzino O., Fuselli J.J., Botto F., de Arenaza D.P., Bahit C., Dadone J., and PACS Group of Investigators. Relative value of N-terminal probrain natriuretic peptide, TIMI risk score, ACC/AHA prognostic classification and other risk markers in patients with non-ST elevation coronary syndromes. Eur Heart J 25 (2004) 859-866